Laboratory Proficiency Testing Market Size & Growth Forecast 2027–2036, By Segments (Industry, Technology, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Laboratory Proficiency Testing Market size was over USD 1.7 billion in 2026 and is likely to grow at a 5.8% CAGR between 2027 and 2036, surpassing USD 2.99 billion by 2036. The industry revenue for 2027 is estimated at USD 1.78 billion.
Get more details on this report
Request Free Sample ReportLaboratory Proficiency Testing Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 47.05% share, supported by mature lab infrastructure, high accreditation standards, and widespread use of external quality assessment across clinical and diagnostic laboratories.
- Asia Pacific is expanding at 7.57% CAGR due to rising lab capacity, stronger regulatory focus on accuracy, and increasing adoption of standardized quality and accreditation frameworks.
Segment Momentum
- Clinical Diagnostics captured 34.69% of the market in 2026 as laboratories require ongoing proficiency testing to maintain quality assurance, result accuracy, and consistency across routine testing operations.
- Chromatography is the fastest-growing technology segment, driven by increasing demand for performance verification and analytical accuracy in complex testing workflows that rely on precise measurement methods.
Market Expansion Drivers
- Increasing foodborne illness outbreaks driving demand for validated laboratory testing standards.
- Expanding cannabis legalization increasing need for compliant potency and contaminant testing programs.
- Rising adoption of AI-enabled laboratory traceability systems strengthening proficiency testing requirements.
Leading Market Participants
- Leading companies in the laboratory proficiency testing market include LGC Limited (United Kingdom), Bio-Rad Laboratories, Inc. (United States), Randox Laboratories Ltd. (United Kingdom), Merck KGaA (Germany), WEQAS (United Kingdom), BIPEA (France), NSI Lab Solutions, Inc. (United States), INSTAND e.V. (Germany), Absolute Standards, Inc. (United States), College of American Pathologists (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.7 billion
- 2027 Estimated Market Size: USD 1.78 billion.
- Projected Market Size: USD 2.99 billion by 2036
- Growth Forecast: 5.8% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Clinical Diagnostics (Industry) | Cell Culture (Technology) | Hospitals (End-use)
- Emerging Opportunity Segment: Cannabis (Industry) | Chromatography (Technology) | Contract Research Organizations (End-use)
Market Growth Drivers and Industry Trends
Increasing foodborne illness outbreaks driving demand for validated laboratory testing standards
Increasing foodborne illness outbreaks are strengthening the laboratory proficiency testing market by placing greater emphasis on the accuracy, reliability, and consistency of analytical testing performed by food laboratories. Proficiency testing programs allow laboratories to compare their analytical performance against established benchmarks and identify weaknesses in sample preparation, detection, measurement, or reporting procedures. As food safety authorities and testing facilities seek greater confidence in pathogen and contaminant detection, participation in external quality assessment programs becomes increasingly important for demonstrating technical competence and maintaining reliable testing practices. Greater scrutiny of food safety workflows is also encouraging laboratories to strengthen quality assurance procedures across microbiological and chemical testing.
Expanding cannabis legalization increasing need for compliant potency and contaminant testing programs
The laboratory proficiency testing market is gaining support from the expansion of legal cannabis markets, which is increasing requirements for reliable testing of product potency, composition, and contaminants. Cannabis laboratories must demonstrate that analytical methods can consistently measure cannabinoids and identify substances such as pesticides, heavy metals, residual solvents, and microbial contaminants. Proficiency testing provides an independent mechanism for evaluating laboratory performance and supporting confidence in reported analytical results, particularly in regulated environments where testing accuracy is closely linked to consumer safety and product compliance. As testing requirements become more established across legal cannabis supply chains, laboratories are placing greater emphasis on standardized quality control and analytical competency.
Rising adoption of AI-enabled laboratory traceability systems strengthening proficiency testing requirements
Increasing use of AI-enabled traceability and laboratory management systems is strengthening the laboratory proficiency testing market as greater digitalization raises expectations for transparent, reproducible, and auditable analytical workflows. AI-supported systems can improve sample tracking, data management, anomaly identification, and documentation, but laboratories must still demonstrate that analytical processes and reported results remain accurate and consistent. Proficiency testing can provide an external validation mechanism for laboratory performance while complementing digital quality systems and automated records. Greater integration of intelligent laboratory technologies is also increasing the need for robust data integrity practices that allow test results and quality assessments to be traced across the analytical workflow.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing foodborne illness outbreaks driving demand for validated laboratory testing standards | 2.00% | High | North America, Europe | High | Near Term |
| Expanding cannabis legalization increasing need for compliant potency and contaminant testing programs | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Rising adoption of AI-enabled laboratory traceability systems strengthening proficiency testing requirements | 1.50% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for 47.05% of the laboratory proficiency testing market in 2026, supported by well-established laboratory quality systems, rigorous accreditation requirements, and widespread emphasis on analytical accuracy and diagnostic reliability. Healthcare, pharmaceutical, environmental, and food testing laboratories increasingly rely on external proficiency assessments to validate testing performance, identify analytical inconsistencies, and maintain compliance with quality standards. The region’s mature laboratory infrastructure and continued focus on quality assurance reinforce sustained demand for proficiency testing services.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, propelled by expanding healthcare and pharmaceutical testing capacity, increasing laboratory accreditation, and efforts to strengthen quality management practices. Rising investment in diagnostic infrastructure and greater adoption of standardized testing procedures are broadening the need for external performance evaluation across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Standardization ExcellenceGermany emphasizes laboratory proficiency testing to maintain measurement accuracy across industrial, healthcare, and research laboratories. German laboratories actively participate in interlaboratory comparisons to align with international standards while supporting advanced manufacturing and scientific testing requirements.
France 🇫🇷
Healthcare Quality AssuranceFrance continues to strengthen laboratory proficiency testing through rigorous clinical diagnostics and public health quality initiatives. French laboratories emphasize routine participation in proficiency schemes to improve testing reliability and maintain confidence across regulated analytical environments.
Italy 🇮🇹
Diagnostic Performance SupportItaly relies on laboratory proficiency testing to improve analytical performance across healthcare, environmental monitoring, and food testing laboratories. Italian organizations increasingly adopt structured external quality assessment programs to enhance laboratory credibility and support consistent diagnostic outcomes.
Japan 🇯🇵
Precision Validation FrameworkJapan prioritizes highly reliable laboratory proficiency testing to reinforce precision across pharmaceutical, food safety, and healthcare applications. The country's laboratories increasingly integrate digital quality management practices with proficiency assessment to improve operational consistency and regulatory confidence.
South Korea 🇰🇷
Innovation-Driven ComplianceSouth Korea is expanding laboratory proficiency testing alongside investments in biotechnology, diagnostics, and advanced analytical services. Laboratories in South Korea focus on demonstrating testing reliability through external quality assessment programs that support both domestic compliance and international collaboration.
United States 🇺🇸
Regulatory Quality FocusThe U.S. laboratory proficiency testing market is shaped by stringent accreditation requirements and continuous quality assurance across clinical, pharmaceutical, and environmental laboratories. Organizations in the U.S. increasingly prioritize external proficiency programs to strengthen compliance, improve analytical consistency, and support laboratory credibility.
Segment Leadership and Growth Trends
Laboratory Proficiency Testing Market Share (%), by Industry, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportIndustry Segment Analysis: Clinical Diagnostics (Largest Segment) vs Cannabis (Fastest-Growing Segment)
The clinical diagnostics segment led the laboratory proficiency testing market with a 34.69% share in 2026, supported by the critical need to maintain accuracy, consistency, and reliability across diagnostic laboratory operations. Proficiency testing allows laboratories to evaluate analytical performance against established expectations and identify potential gaps in testing procedures. As diagnostic laboratories handle increasingly sophisticated testing workflows, ongoing quality assurance remains essential for producing dependable results and supporting confidence in laboratory-based clinical decisions.
The cannabis industry is emerging as the fastest-growing segment as laboratories involved in cannabis testing require reliable methods for evaluating product quality, composition, and safety. Proficiency testing can help laboratories demonstrate analytical competence and improve consistency across testing procedures. As testing requirements become more important within the cannabis value chain, demand for standardized quality-assurance practices is supporting greater adoption of proficiency testing services.
Technology Segment Analysis: Cell Culture (Largest Segment) vs Chromatography (Fastest-Growing Segment)
Cell culture accounted for the largest share of the laboratory proficiency testing market at 28.97% in 2026, reflecting its importance across laboratory workflows involving biological research, pharmaceutical development, and related testing activities. Proficiency assessment in cell culture helps laboratories maintain consistency in experimental processes and evaluate the reliability of their procedures. The increasing use of biological models and controlled laboratory environments continues to reinforce the need for dependable quality-management practices around cell-based techniques.
Chromatography is projected to register the fastest growth as laboratories increasingly require precise analytical techniques for separating, identifying, and quantifying complex substances. Its broad relevance to pharmaceutical, chemical, food, environmental, and other testing applications creates substantial demand for reliable analytical performance. Proficiency testing supports laboratories by helping assess method accuracy and consistency, making it increasingly valuable as chromatography-based testing becomes more sophisticated and widely utilized.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Industry | Clinical Diagnostics, Pharmaceuticals, Microbiology, Cannabis | Clinical Diagnostics | Cannabis |
| Technology | Cell Culture, Spectrometry, Polymerase Chain Reaction, Chromatography, Immunoassays, Others | Cell Culture | Chromatography |
| End-use | Hospitals, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Laboratories, Independent Laboratories, Specialty Laboratories | Hospitals | Contract Research Organizations |
Competitive Landscape and Market Positioning
Major players in the laboratory proficiency testing market:
1. LGC Limited (United Kingdom)
2. Bio-Rad Laboratories Inc. (United States)
3. Randox Laboratories Ltd. (United Kingdom)
4. Merck KGaA (Germany)
5. WEQAS (United Kingdom)
6. BIPEA (France)
7. NSI Lab Solutions Inc. (United States)
8. INSTAND e.V. (Germany)
9. Absolute Standards Inc. (United States)
10. College of American Pathologists (United States)
The laboratory proficiency testing market is expanding as laboratories prioritize accuracy, standardization, and compliance across diagnostic and analytical processes. Growing implementation of quality assurance programs and external validation procedures is strengthening demand for proficiency testing services. Advancements in laboratory automation and specialized testing protocols are also contributing to market development.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| LGC Limited (United Kingdom) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Randox Laboratories Ltd. (United Kingdom) | |||||||
| Merck KGaA (Germany) | |||||||
| WEQAS (United Kingdom) | |||||||
| BIPEA (France) | |||||||
| NSI Lab Solutions Inc. (United States) | |||||||
| INSTAND e.V. (Germany) | |||||||
| Absolute Standards Inc. (United States) | |||||||
| College of American Pathologists (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Apollo Diagnostics | Nov-25 | Apollo Diagnostics launched its Digi-Smart Central Reference Laboratory in Chennai, a 45,000-square-foot automated facility integrating five major lab disciplines. By leveraging advanced robotics, AI-driven algorithms, and cloud-based infrastructure, the lab is designed to process 100,000+ samples daily, significantly reducing turnaround times and establishing a benchmark for high-throughput diagnostic proficiency in India and Southeast Asia. |
| Cormay Diagnostics | Feb-25 | Cormay Diagnostics entered a strategic partnership with Randox to integrate its IVD solutions into the Randox International Quality Assessment Scheme (RIQAS). This collaboration provides Cormay with access to one of the world's largest External Quality Assessment (EQA) frameworks, enabling global proficiency benchmarking for its diagnostic platforms across a network of over 70,000 participating laboratories. |
| College of American Pathologists | Nov-24 | The College of American Pathologists (CAP) introduced a new Proficiency Testing (PT) reporting framework tailored for in vitro diagnostics (IVD) manufacturers. The initiative aims to enhance the integration of laboratory feedback into diagnostic development, fostering higher quality and greater accuracy across the diagnostic landscape by aligning manufacturer performance metrics with real-world clinical testing requirements. |
| Bio-Rad Laboratories | Oct-24 | Bio-Rad Laboratories launched the External Quality Assurance Services (EQAS) Specialty Immunoassay (SPIA) program. The program consolidates 13 complex analytes into a single, ISO/IEC 17043-accredited testing service. By streamlining EQA workflows and reducing the need for multiple independent assessments, the solution provides clinical laboratories with a cost-effective, standardized method for monitoring assay performance in disease areas like sepsis and diabetes. |
| BIPEA | Jun-24 | BIPEA launched the "PT 56A" experimental program focusing on the detection of microbial contaminants in flour. By introducing artificial contamination challenges for laboratory proficiency evaluation, the program aims to standardize detection protocols for pathogens in food supply chains, thereby improving quality control and safety validation for food-testing laboratories. |
| College of American Pathologists | Mar-23 | The College of American Pathologists launched a specialized proficiency testing program for the monkeypox (mpox) virus. The program provides laboratories with simulated specimens containing whole killed virus to validate molecular testing protocols, supporting accurate, standardized diagnostic outcomes and reinforcing public health response capabilities during emerging infectious disease outbreaks. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Laboratory Proficiency Testing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Proficiency Testing Program Type | Microbiology Testing, Chemistry Testing, Molecular Testing, Immunology Testing, Hematology Testing, Toxicology Testing |
| Analyte Category | Infectious Disease Analytes, Clinical Chemistry Analytes, Hematology Analytes, Immunology Analytes, Molecular & Genetic Analytes, Environmental & Food Analytes |
| Delivery Mode | Physical Sample-Based Programs, Digital & Virtual Programs, Hybrid Programs |
Laboratory Proficiency Testing Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Digital Proficiency Testing Evolution |
|
| Accreditation Impact Assessment |
|
| Global Laboratory Network Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of laboratory proficiency testing?
What is the expected industry size of laboratory proficiency testing by 2036?
Why is proficiency testing becoming increasingly important for regulated laboratory environments?
How are AI-enabled laboratory systems influencing proficiency testing adoption?
Why does Clinical Diagnostics hold the largest share of the laboratory proficiency testing market?
Which technology segment is growing fastest in the laboratory proficiency testing market?
Why does North America lead the laboratory proficiency testing market?
What is driving Asia Pacific’s growth in proficiency testing?
Which organizations are considered leaders in the laboratory proficiency testing landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization